BACKGROUND: Present studies on the reversal of multi-drug resistance (MDR) are almost entirely limited to in vitro systems, and are seldom carried out in vivo.
BACKGROUND: Many investigators have indicated that overexpression and ampliifcation of the human proto-oncogene c-erbB-2 is an independent prognostic factor for